Inflammatory Signatures of Tinnitus in Patients and Mice

Tinnitus is a common refractory disorder with complex mechanisms. Emerging evidence suggests that inflammation plays key roles in tinnitus pathogenesis; however, its overall inflammatory signatures remain underinvestigated. This study integrates transcriptomic data from patients with tinnitus and a noise-induced mouse model to identify conserved neuroinflammatory pathways....

Continue reading at PubMed →

No actionable change yet — while inflammation is implicated in tinnitus, no tested anti-inflammatory treatment for tinnitus is ready for clinical adoption based on this study alone.

Identifying specific inflammatory markers shared across human tinnitus patients and animal models opens a credible biological pathway for future drug or immunotherapy targets, potentially reshaping how tinnitus is treated.

1. 01Study published in Neuroscience Bulletin (DOI: 10.1007/s12264-026-01684-5) characterizes inflammatory signatures in both tinnitus patients and mouse models.
2. 02Findings support inflammation as a key mechanism in tinnitus development (pathogenesis), not just a bystander effect.
3. 03Translational design (humans + mice) strengthens the biological plausibility of the inflammatory pathway.
4. 04Specific inflammatory markers identified could serve as future biomarkers or therapeutic targets.
5. 05Does not test any treatment; clinical translation remains a future step.

PMID

42573663

DOI

10.1007/s12264-026-01684-5.

Journal

Neuroscience Bulletin

Publication type

research_article

Evidence level

3

Population

Tinnitus patients and a mouse model of tinnitus

Intervention

Characterization of inflammatory biomarker profiles in tinnitus subjects

Comparator

Non-tinnitus controls (implied by case-control design in patients and mouse model)